Olin, M.R.; Ampudia-Mesias, E.; Pennell, C.A.; Sarver, A.; Chen, C.C.; Moertel, C.L.; Hunt, M.A.; Pluhar, G.E.
Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma. Cancers 2019, 11, 137.
https://doi.org/10.3390/cancers11020137
AMA Style
Olin MR, Ampudia-Mesias E, Pennell CA, Sarver A, Chen CC, Moertel CL, Hunt MA, Pluhar GE.
Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma. Cancers. 2019; 11(2):137.
https://doi.org/10.3390/cancers11020137
Chicago/Turabian Style
Olin, Michael R., Elisabet Ampudia-Mesias, Christopher A. Pennell, Aaron Sarver, Clark C. Chen, Christopher L. Moertel, Matthew A. Hunt, and G. Elizabeth Pluhar.
2019. "Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma" Cancers 11, no. 2: 137.
https://doi.org/10.3390/cancers11020137
APA Style
Olin, M. R., Ampudia-Mesias, E., Pennell, C. A., Sarver, A., Chen, C. C., Moertel, C. L., Hunt, M. A., & Pluhar, G. E.
(2019). Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma. Cancers, 11(2), 137.
https://doi.org/10.3390/cancers11020137